Shares of Acelyrin Inc. fell by more than 36% following the release of Phase II clinical trial data for its drug lonigutamab, developed for the treatment of thyroid eye disease (TED). The market reacted negatively...

"Net inflows totaled $1.1 billion," according to CoinGlass analysts' data for January 6, 2025. Following a slow start to the year, Bitcoin and Ethereum ETFs have once again captured investors' attention. In the first two...

General Motors (GM) saw a 4% increase in sales in 2024, reaching 2.7 million vehicles, marking its best performance since 2019. In the fourth quarter, sales grew by 21% compared to the previous year. The...

A super cycle of 2025 is a reality,” said Khushboo Khullar, partner at Lightning Ventures. According to her, regulatory reforms under the Trump administration could become the main catalyst for growth. Bitcoin (BTC-USD) reached $99,871...

Nike (NKE) delivered positive results for the second fiscal quarter amid restructuring efforts led by new CEO Elliott Hill. The company reported revenue of $12.35 billion, surpassing the forecasted $12.13 billion, but falling short of...